Ingrid Brands
Vorstandsvorsitzender bei BioStrand BV
Profil
Ingrid Brands is the founder and current Chief Executive Officer of BioStrand BV, which is founded in 2019.
She is also currently a Director at BioKey BV since 2020 and at BioClue BV since 2019.
Aktive Positionen von Ingrid Brands
| Unternehmen | Position | Beginn |
|---|---|---|
BioClue BV
 BioClue BV Medical/Nursing ServicesHealth Services Founded in 2019, BioClue BV is a subsidiary of ImmunoPrecise Antibodies Ltd. that provides biotechnology services and specializes in the development of antibody therapeutics. The company is based in Hamont-Achel, Belgium. | Direktor/Vorstandsmitglied | 06.02.2019 |
BioKey BV
 BioKey BV Real Estate DevelopmentFinance Part of ImmunoPrecise Antibodies Ltd., BioKey BV is a company based in Hamont-Achel, Belgium. | Direktor/Vorstandsmitglied | 15.05.2020 |
BioStrand BV
 BioStrand BV Miscellaneous Commercial ServicesCommercial Services Part of ImmunoPrecise Antibodies Ltd., BioStrand BV is a Belgian company that offers an AI-powered biotherapeutic SaaS platform to accelerate drug discovery. The company is based in Diepenbeek, Belgium. BioStrand's LensAI provides data solutions for simplified management, insights, integration, and collaboration. The platform helps researchers discover drug discovery insights faster and master big omics data challenges with multi-dimensional integration. The company was founded in 2019 by Dirk Van Hyfte and Ingrid Brands, with Ingrid Brands serving as the CEO since then. BioStrand was acquired by ImmunoPrecise Netherlands BV on April 14, 2022 for $35.10 million. | Vorstandsvorsitzender | 06.02.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BioClue BV
BioClue BV Medical/Nursing ServicesHealth Services Founded in 2019, BioClue BV is a subsidiary of ImmunoPrecise Antibodies Ltd. that provides biotechnology services and specializes in the development of antibody therapeutics. The company is based in Hamont-Achel, Belgium. | Health Services |
BioKey BV
BioKey BV Real Estate DevelopmentFinance Part of ImmunoPrecise Antibodies Ltd., BioKey BV is a company based in Hamont-Achel, Belgium. | Finance |
BioStrand BV
BioStrand BV Miscellaneous Commercial ServicesCommercial Services Part of ImmunoPrecise Antibodies Ltd., BioStrand BV is a Belgian company that offers an AI-powered biotherapeutic SaaS platform to accelerate drug discovery. The company is based in Diepenbeek, Belgium. BioStrand's LensAI provides data solutions for simplified management, insights, integration, and collaboration. The platform helps researchers discover drug discovery insights faster and master big omics data challenges with multi-dimensional integration. The company was founded in 2019 by Dirk Van Hyfte and Ingrid Brands, with Ingrid Brands serving as the CEO since then. BioStrand was acquired by ImmunoPrecise Netherlands BV on April 14, 2022 for $35.10 million. | Commercial Services |
